Aytu BioPharma Q1 revenue beats estimates on higher EXXUA sales
Aytu BioPharma Q1 revenue beats estimates on higher EXXUA sales Overview U.S. CNS drugmaker's fiscal
Aytu BioPharma Q1 revenue beats estimates on higher EXXUA sales Overview U.S. CNS drugmaker's fiscal